COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,624 Articles (22,913 medRxiv, 8,711 bioRxiv)

Most recent first Previous |  Page 569: Articles 5681-5690  | Next

A large-scale serological survey in pets from October 2020 through June 2021 in France shows significantly higher exposure to SARS-CoV-2 in cats
Fritz, M., Elguero, E., Becquart, P., de Riols de Fonclare, D., Garcia, D., Beurlet, S., Denolly, S., Boson, B., Rosolen, S. G., Cosset, F.-L., Briend-Marchal, A., Legros, V., Leroy, E. M.
10.1101/2022.12.23.521567 — Posted: 2022-12-26
Risk of Suicide Attempts and Self-Directed Violence after SARS-CoV-2 Infection: Outcomes from an Emulated Trial of a Nationwide Observational Matched Cohort of US Veterans
Hynes, D. M., Niederhausen, M., Chen, J., Shahoumian, T., Rowneki, M., Hickok, A., Shepherd-Banigan, M., Hawkins, E. J., Naylor, J., Teo, A. R., Govier, D. J., Berry, K., McCready, H. D., Osborne, T. F., Wong, E. S., Hebert, P. L., Smith, V. A., Bowling, C. B., Boyko, E. J., Ioannou, G. N., Iwashyna, T. J., Maciejewski, M. L., O'Hare, A. M., Viglianti, E. M., Bohnert, A.
10.1101/2022.12.23.22283902 — Posted: 2022-12-26
EFFECTIVENESS OF CASIRIVIMAB-IMDEVIMAB AND SOTROVIMAB MONOCLONAL ANTIBODY TREATMENT AMONG HIGH-RISK PATIENTS WITH SARS-CoV-2 INFECTION: A REAL-WORLD EXPERIENCE
Tanriover, B., Gungor, A. B., Al-Obaidi, M., Thajudeen, B., Wong, R., Mansour, I., Zangeneh, T., Johnson, K., Low, N., Alam, R., Gonzalez, E., Sandikci, B., Muruganpandian, S., Gupta, G., Bedrick, E., Saridogan, T., Mendoza, K.
10.1101/2022.12.23.22283921 — Posted: 2022-12-26
Comparison of multiple whole-genome and Spike-only sequencing protocols for estimating variant frequencies via wastewater-based epidemiology
Winder, L. A., Parsons, P., Horsburgh, G., Maher, K., Hipperson, H., Wierzbicki, C., Jeffries, A. R., Brown, M. R., Fairbrother-Browne, A., Denise, H., Khalifa, M. S., Bassano, I., van Aerle, R., Williams, R., Farcas, K., Paterson, S., Blackwell, P. G., Burke, T.
10.1101/2022.12.22.22283855 — Posted: 2022-12-26
Pediatric Nirmatrelvir/Ritonavir Prescribing Patterns During the COVID-19 Pandemic
Bose Brill, S., Hirabayashi, K., Pajor, N. M., Rao, S., Mejias, A., Jhaveri, R., Forrest, C. B., Bailey, C., Christakis, D. A., Thacker, D., Lorman, V., Hanley, P. C., Patel, P., Cogen, J., Block, J., Prahalad, P., Lee, G.
10.1101/2022.12.23.22283868 — Posted: 2022-12-26
US Public Opinion as to Whether "The Pandemic is Over," September to October 2022
Czeisler, M. E., Weaver, M. D., Lane, R. I., Rajaratnam, S. M., Howard, M. E., Czeisler, C. A.
10.1101/2022.12.23.22283899 — Posted: 2022-12-26
Methodological approaches to optimize multiplex oral fluid SARS-CoV-2 IgG assay performance and correlation with serologic and neutralizing antibody responses
Pisanic, N., Antar, A. A. R., Kruczynski, K. L., Gregory Rivera, M., Dhakal, S., Spicer, K., Randad, P. R., Pekosz, A., Klein, S. L., Betenbaugh, M. J., Detrick, B., Clarke, W., Thomas, D. L., Manabe, Y. C., Heaney, C. D.
10.1101/2022.12.22.22283858 — Posted: 2022-12-26
Seroprevalence of anti-SARS-CoV-2 antibodies before and after implementation of anti-COVID-19 vaccination among hospital staff in Bangui, Central African Republic
MANIRAKIZA, A., Malaka, C., Mossoro-Kpinde, H. D., Yambiyo, B. M., Mossoro-Kpinde, C. D., Fandema, E., Niamathe Yakola, C., Doyama-Woza, R., Kangale-Wando, I. M., Kosh Komba, J. E., Nzapali Guiagassomon, S. M. B., Namsenei-Dankpe, L. J.-V. d. l. G., Coti-Reckoundji, C. S. G., Behouda, M., Gody, J. C., Gresenguet, G., Vernet, G., Vernet, M. A., Nakoune, E.
10.1101/2022.12.22.22283871 — Posted: 2022-12-26
A machine learning-based phenotype for long COVID in children: an EHR-based study from the RECOVER program
Lorman, V., Razzaghi, H., Song, X., Morse, K., Utidjian, L. H., Allen, A. J., Rao, S., Rogerson, C., Bennett, T. D., Morizono, H., Eckrich, D., Jhaveri, R. D., Huang, Y., Ranade, D., Pajor, N. M., Lee, G. M., Forrest, C. B., Bailey, L. C.
10.1101/2022.12.22.22283791 — Posted: 2022-12-26
Comparative effectiveness of four COVID-19 vaccines, BNT162b2 mRNA, mRNA-1273, ChAdOx1 nCov-19 and NVX-CoV2373 against SARS-CoV-2 B.1.1.529 (Omicron) infection
Liu, B., Stepien, S., Qian, J., Gidding, H., Nicopoulos, K., Amin, J., Cheng, A., Macartney, K.
10.1101/2022.12.22.22283869 — Posted: 2022-12-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).